Search - tctmd.com

Displaying 41 - 60 of 230

Sort: Relevancy | Date

News Industry News

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

April 26, 2016

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

Presentation ISET 2016

Successfully Traversing the Occluded SFA Stent with a Mid-Stent Puncture

Presenter: Gary M. Ansel

February 07, 2016

Presentation ISET 2016

Drug-Coated Balloons in the SFA: A Class of Devices with Differentiated Outcomes?

Presenter: Thomas Zeller

February 07, 2016

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

News Industry News

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

October 27, 2015

Presentation TCT 2015

IN.PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions - Two-Year Outcomes

Presenter: Cindy L. Grines, John R. Laird Jr

October 14, 2015

Presentation TCT 2015

When and How to Treat a Claudicant With an Occluded SFA

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

IN_PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions – Two-Year Outcomes

Presenter: John R. Laird Jr.

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

Presentation TCT 2015

Next-Generation DCBs: Alternative Coatings and Drug-Delivery Platforms for SFA Intervention

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Juan F. Granada

October 12, 2015

Presentation TCT 2015

12 Month Outcomes From the Lutonix Global SFA Real-World Registry

Presenter: John R. Laird Jr, Gunnar Tepe, Marcus Thieme

October 12, 2015

Presentation TCT 2015

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, John R. Laird Jr

October 12, 2015

Presentation TCT 2015

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Presenter: Hans Krankenberg, Lindsay S. Machan, Herbert D. Aronow

October 11, 2015

Presentation TCT 2015

Management Strategies for SFA/Popliteal In-Stent Restenosis

Presenter: Hans Krankenberg, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

Embolic Protection in Lower-Extremity Intervention: Where Does It Make the Most Sense?

Presenter: Hans Krankenberg, Lindsay S. Machan, Venkatesh Ramaiah

October 11, 2015

Advertisement

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Successfully Traversing the Occluded SFA Stent with a Mid-Stent Puncture

Drug-Coated Balloons in the SFA: A Class of Devices with Differentiated Outcomes?

First Patients Enrolled in the Gore RELINE MAX Clinical Study

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

IN.PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions - Two-Year Outcomes

When and How to Treat a Claudicant With an Occluded SFA

IN_PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions – Two-Year Outcomes

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

Next-Generation DCBs: Alternative Coatings and Drug-Delivery Platforms for SFA Intervention

12 Month Outcomes From the Lutonix Global SFA Real-World Registry

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Management Strategies for SFA/Popliteal In-Stent Restenosis

Embolic Protection in Lower-Extremity Intervention: Where Does It Make the Most Sense?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content